East Tallinn Central Hospital is a hospital located in Tallinn, Estonia in the Veerenni subdistrict, on Ravi 18 street.

During the past decade, East Tallinn Central Hospital; Neurology Department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "East Tallinn Central Hospital; Neurology Department" are "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "East Tallinn Central Hospital; Neurology Department" in a lesser frequency.

Most popular intervention types in "East Tallinn Central Hospital; Neurology Department" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "East Tallinn Central Hospital; Neurology Department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "East Tallinn Central Hospital; Neurology Department". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in East Tallinn Central Hospital; Neurology Department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in East Tallinn Central Hospital; Neurology Department, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".